Compile Data Set for Download or QSAR
Report error Found 14 of affinity data for UniProtKB/TrEMBL: Q9UF12
TargetHydroxyproline dehydrogenase [147-515](Human)
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433365(US10562844, Compound 16)
Affinity DataIC50: 2.90E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetHydroxyproline dehydrogenase [147-515](Human)
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433361(US10562844, Compound 13)
Affinity DataIC50: 3.20E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetHydroxyproline dehydrogenase [147-515](Human)
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433364(US10562844, Compound 14)
Affinity DataIC50: 3.30E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetHydroxyproline dehydrogenase [147-515](Human)
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433359(US10562844, Compound 11)
Affinity DataIC50: 3.70E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetHydroxyproline dehydrogenase [147-515](Human)
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433363(US10562844, Compound 15)
Affinity DataIC50: 3.70E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetHydroxyproline dehydrogenase [147-515](Human)
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433358(US10562844, Compound 10)
Affinity DataIC50: 3.80E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetHydroxyproline dehydrogenase [147-515](Human)
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433360(US10562844, Compound 8)
Affinity DataIC50: 4.80E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetHydroxyproline dehydrogenase [147-515](Human)
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433357(US10562844, Compound 7)
Affinity DataIC50: 6.00E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetHydroxyproline dehydrogenase [147-515](Human)
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433355(US10562844, Compound 9)
Affinity DataIC50: 6.30E+5nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetHydroxyproline dehydrogenase [147-515](Human)
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433349(US10562844, Compound 1)
Affinity DataIC50: 2.90E+6nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetHydroxyproline dehydrogenase [147-515](Human)
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433351(US10562844, Compound 5)
Affinity DataIC50: 2.10E+6nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetHydroxyproline dehydrogenase [147-515](Human)
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433354(US10562844, Compound 2)
Affinity DataIC50: 1.50E+6nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetHydroxyproline dehydrogenase [147-515](Human)
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433356(US10562844, Compound 6)
Affinity DataIC50: 1.00E+7nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent

TargetHydroxyproline dehydrogenase [147-515](Human)
Wake Forest University Health Sciences

US Patent
LigandPNGBDBM433362(US10562844, Compound 12)
Affinity DataIC50: 1.00E+6nMAssay Description:In an effort to biochemically and structurally characterize human HYPDH, we have evaluated numerous expression constructs (>15) in Escherichia coli w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2020
Entry Details
Go to US Patent